Nu.Q® Discover tools provide drug developers and scientists with a range of rapid epigenetic profiling assays across pre-clinical and clinical development pathways from discovery to market ready ...
On March 4, 2025, VolitionRx (NYSE:VNRX) made a significant milestone announcement that, for the first time, Nu.Q Discover biomarkers will be utilized in a human clinical study. An unnamed leading ...
SALT LAKE CITY, March 25, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback